Stockscreener 앱 받기
4.49
2.05%
0.09
Trisalus Life Sciences Inc 주식(TLSI)의 최신 뉴스
TriSalus Life Sciences (NASDAQ:TLSI) Trading Up 2%Time to Buy? - MarketBeat
Bull Run: Will TriSalus Life Sciences Inc benefit from rate cuts2026 Retail & Weekly Hot Stock Watchlists - baoquankhu1.vn
Sentiment Recap: Is TriSalus Life Sciences Inc Equity Warrant a strong growth stock2026 Earnings Impact & Consistent Profit Alerts - baoquankhu1.vn
TLSI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Volume Summary: Is TriSalus Life Sciences Inc Equity Warrants growth already priced in2026 Price Swings & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Aug Swings: Is TriSalus Life Sciences Inc stock a value trap2026 Risk Factors & Reliable Price Breakout Signals - baoquankhu1.vn
TriSalus Life Sciences to Present New Data at 2026 Radiology Conference - National Today
TriSalus to present drug delivery data at radiology meeting By Investing.com - Investing.com South Africa
TriSalus to present drug delivery data at radiology meeting - Investing.com
TriSalus brings liver and uterine treatment data to SIR 2026 - Stock Titan
TriSalus to elevate director to chief medical officer role - BizWest
Trisalus Life Sciences, Inc. Appoints Richard Marshall, M.D., as Chief Medical Officer, Effective June 29, 2026 - marketscreener.com
TriSalus names Richard Marshall as chief medical officer By Investing.com - Investing.com India
TriSalus Life Sciences, Inc. Files Form 8-K on April 1, 2026 Announcing Press Release and Company Information - Minichart
TriSalus names Richard Marshall as chief medical officer - Investing.com
TriSalus Life Sciences Names Richard Marshall Chief Medical Officer - TipRanks
Transcend Appoints Elizabeth Jackson as Senior Vice President of Marketing - Weekly Voice
TriSalus Life Sciences Appoints Richard Marshall, M.D., as Chief Medical Officer - Weekly Voice
Oncology company TriSalus taps interventional radiologist as medical chief - Stock Titan
TriSalus Life Sciences (TLSI) taps Richard Marshall, M.D., as Chief Medical Officer - Stock Titan
TLSI Technical Analysis & Stock Price Forecast - Intellectia AI
Laramie’s Unlocked Labs fights kidney stones with enzymes - BizWest
Director converts 100,000 TriSalus (TLSI) preferred shares into common - Stock Titan
TLSI Should I Buy - Intellectia AI
Revenue Check: Why is TriSalus Life Sciences Inc stock going up2026 Key Highlights & Entry Point Confirmation Signals - baoquankhu1.vn
Aug PreEarnings: Is TriSalus Life Sciences Inc Equity Warrant in a long term uptrend2026 Market Mood & Technical Buy Zone Confirmation - baoquankhu1.vn
Executive pay and board elections at TriSalus (TLSI) 2026 virtual shareholder meeting - Stock Titan
Aug PreEarnings: Is TriSalus Life Sciences Inc Equity Warrants growth already priced inDip Buying & Weekly Top Performers Watchlists - baoquankhu1.vn
Published on: 2026-03-26 07:22:01 - baoquankhu1.vn
Momentum Shift: Does TriSalus Life Sciences Inc have pricing power2026 Top Gainers & Technical Confirmation Alerts - baoquankhu1.vn
What is Northland Securities' Estimate for TLSI Q1 Earnings? - MarketBeat
TLSI SEC FilingsTriSalus Life Sciences Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Selling: TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $17,998.54 in Stock - Defense World
Insider Selling: TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $61,384.40 in Stock - Defense World
Weekly Earnings: Can TriSalus Life Sciences Inc Equity Warrant keep up with sector leadersMarket Risk Analysis & Fast Exit and Entry Trade Guides - baoquankhu1.vn
TriSalus Life Sciences launches proposed public stock offering - MSN
Aug Movers: Is TriSalus Life Sciences Inc Equity Warrant a top pick in the sector2026 Price Targets & Community Consensus Trade Signals - baoquankhu1.vn
RSI Check: Is TriSalus Life Sciences Inc Equity Warrant forming a bullish divergenceMarket Volume Summary & AI Powered Market Trend Analysis - baoquankhu1.vn
Top TriSalus Executives Make Major Moves With Insider Stock Sales - TipRanks
TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $17,998.54 in Stock - MarketBeat
TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $61,384.40 in Stock - MarketBeat
Szela, CEO of TriSalus, sells $79k in TLSI stock By Investing.com - Investing.com India
Szela, CEO of TriSalus, sells $79k in TLSI stock - Investing.com
TriSalus Life Sciences (TLSI) chief regulatory officer sells $14509 in stock - Investing.com
Trisalus Life Sciences’ CCO Marshak sells $14k in TLSI stock - Investing.com UK
Devlin Jodi, TriSalus Life Sciences chief, sells $13k in TLSI stock - Investing.com India
TriSalus Life Sciences chief of research Cox sells $13k in TLSI stock - Investing.com
TriSalus (TLSI) executive sells 3,207 shares to satisfy RSU tax withholding - Stock Titan
TriSalus (TLSI) Chief of Research has 3,184 shares sold for tax withholding - Stock Titan
TriSalus (TLSI) CCO logs small tax-related share disposals, retains over 110K shares - Stock Titan
TriSalus Life Sciences (TLSI) CRO sells shares for taxes - Stock Titan
TriSalus (TLSI) CEO Szela disposes 20,302 shares for tax withholding - Stock Titan
TriSalus publishes preclinical data on drug delivery technology By Investing.com - Investing.com South Africa
Should I invest in TriSalus Life Sciences Inc before earningsWall Street Watch & Technical Buy Zone Confirmations - baoquankhu1.vn
TriSalus publishes preclinical data on drug delivery technology - Investing.com
Animal study from TriSalus pumps more immune drug into liver tumors in models - Stock Titan
Update Recap: What is the dividend yield of TriSalus Life Sciences Inc Equity WarrantRate Hike & Precise Entry and Exit Recommendations - baoquankhu1.vn
2.40%
0.00%
자본화:
|
볼륨(24시간):